L. Shen

发表

The gut microbiota as a booster for radiotherapy: novel insights into radio-protection and radiation injury

Yang Wu, Zhen Zhang, Zhen Zhang, 2023, Experimental Hematology & Oncology.

The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study

Lijun Shen, Zhen Zhang, Bingdong Liu, 2020, Frontiers in Cellular and Infection Microbiology.

Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer.

Junjie Peng, Hans Clevers, Lijun Shen, 2019, Cell stem cell.

Poorer prognosis in young female patients with non-metastatic colorectal cancer: a hospital-based analysis of 5,047 patients in China

Xinxiang Li, Lijun Shen, Zhen Zhang, 2018, Cancer management and research.

Patient‐derived tumor organoids predict responses to irinotecan‐based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

H. Clevers, Chen Hu, Guoqiang Hua, 2022, International journal of cancer.

Quantifying skeletal muscle wasting during chemoradiotherapy with Jacobian calculations for the prediction of survival and toxicity in patients with gastric cancer.

Jiazhou Wang, Lijun Shen, Zhen Zhang, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Protective ileostomy increased the incidence of rectal stenosis after anterior resection for rectal cancer

Lijun Shen, Zhen Zhang, Jing Zhang, 2022, Radiation oncology.

TNF rs1799964 as a Predictive Factor of Acute Toxicities in Chinese Rectal Cancer Patients Treated With Chemoradiotherapy

Q. Wei, Lijun Shen, L. Liang, 2015, Medicine.

Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy

Menghong Sun, Q. Wei, L. Liang, 2015, OncoTargets and therapy.

Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study

Xinxiang Li, Yang Xu, Ye Xu, 2021, PLoS medicine.

Predictive value of MRI-detected extramural vascular invasion in stage T3 rectal cancer patients before neoadjuvant chemoradiation.

Lijun Shen, Yiqun Sun, Yajia Gu, 2018, Diagnostic and interventional radiology.

Regulation of the regeneration of intestinal stem cells after irradiation

Lijun Shen, L. Liang, Guoqiang Hua, 2020, Annals of translational medicine.

Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation

Ye Xu, Lijun Shen, S. Cai, 2022, Frontiers in Immunology.

Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH)

Ye Xu, Lijun Shen, Zhen Zhang, 2022, BMC Cancer.

Reproducibility with repeat CT in radiomics study for rectal cancer

Jiazhou Wang, Weigang Hu, Lijun Shen, 2016, Oncotarget.

Radiomic features of pretreatment MRI could identify T stage in patients with rectal cancer: Preliminary findings

Jiazhou Wang, Weigang Hu, Lijun Shen, 2018, Journal of magnetic resonance imaging : JMRI.

Radiomics features on radiotherapy treatment planning CT can predict patient survival in locally advanced rectal cancer patients

Jiazhou Wang, Lijun Shen, Zhen Zhang, 2019, Scientific Reports.

A novel LARCassigner3 classification predicts outcomes in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: a retrospective training and validation analysis

Lijun Shen, Zhen Zhang, Jing Zhang, 2019, Cancer management and research.

Newly developed 3D in vitro models to study tumor–immune interaction

S. Cai, Guoqiang Hua, Hui Zhang, 2023, Journal of Experimental & Clinical Cancer Research.

Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation

Zhen Zhang, L. Liang, M. Fan, 2014, Radiation oncology.

Disparities in survival for right-sided vs. left-sided colon cancers in young patients: a study based on the Surveillance, Epidemiology, and End Results database (1990–2014)

Lijun Shen, Zhen Zhang, L. Liang, 2018, Cancer management and research.

MicroRNA-223 enhances radiation sensitivity of U87MG cells in vitro and in vivo by targeting ataxia telangiectasia mutated.

W. Gu, Nicholas G Zaorsky, Lijun Shen, 2014, International journal of radiation oncology, biology, physics.

Identification of patients with lymph node metastasis from gastric cancer who may benefit from adjuvant chemoradiotherapy after D2 dissection--do N3 patients benefit from additional radiation?

Lijun Shen, L. Liang, Zhen Zhang, 2016, The British journal of radiology.

Aneuploidy of chromosome 8 and mutation of circulating tumor cells predict pathologic complete response in the treatment of locally advanced rectal cancer.

Lijun Shen, Zhen Zhang, L. Liang, 2018, Oncology letters.

Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells.

Lijun Shen, Zhen Zhang, L. Liang, 2018, International journal of oncology.

A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRacing study

Wenming Zhang, Lijun Shen, Zhen Zhang, 2022, BMC cancer.

Preoperative Chemoradiotherapy Versus Postoperative Chemoradiotherapy for Patients With Locally Advanced Gastric Cancer: A Retrospective Study Based on Propensity Score Analyses

Lijun Shen, Zhen Zhang, Zhen Zhang, 2020, Frontiers in Oncology.

Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study

Lijun Shen, Yanlei Ma, A. Goel, 2020, Clinical Cancer Research.

T3 subclassification using the EMD/mesorectum ratio predicts neoadjuvant chemoradiation outcome in T3 rectal cancer patients.

Lijun Shen, Yiqun Sun, Zhen Zhang, 2018, The British journal of radiology.

Patterns of regional nodal relapse after D2 lymphadenectomy in gastric cancer: rethinking the target volume

Zhen Zhang, L. Liang, G. Li, 2018, OncoTargets and therapy.

Technical Note: A deep learning‐based autosegmentation of rectal tumors in MR images

Jiazhou Wang, J. Lu, Gan Qin, 2018, Medical physics.

Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer

G. He, Lijun Shen, Zhen Zhang, 2016, OncoTargets and therapy.

MRI Radiomics Signature as a Potential Biomarker for Predicting KRAS Status in Locally Advanced Rectal Cancer Patients

Jiazhou Wang, Lijun Shen, Zhen Zhang, 2021, Frontiers in Oncology.

Variations in CT determination of target volume with active breath co-ordinate in radiotherapy for post-operative gastric cancer

Jiazhou Wang, Lijun Shen, L. Liang, 2016, The British journal of radiology.

Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy

Lijun Shen, Zhen Zhang, Jing Zhang, 2019, Cancer medicine.

Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer

Lijun Shen, Zhen Zhang, Xinchen Sun, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study.

Lijun Shen, Zhen Zhang, L. Liang, 2018, The British journal of radiology.

Validation of a rectal cancer outcome prediction model with a cohort of Chinese patients

J. van Soest, A. Dekker, Ying Xiao, 2015, Oncotarget.

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy

Lijun Shen, Zhen Zhang, L. Liang, 2019, Cancer medicine.

ctDNA as a potential prognostic marker for locally advanced rectal cancer patients with ‘watch and wait’ approach.

Lijun Shen, Zhen Zhang, Xue Wu, 2019, Journal of Clinical Oncology.

RIFLE: a Phase II trial of stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer

Jiazhou Wang, Hui Zhang, J. Wan, 2022, Gastroenterology report.

Aneuploidy of chromosome 8 and mutation of circulating tumor cells predict pathologic complete response in the treatment of locally advanced rectal cancer.

Zhen Zhang, L. Liang, Jing Zhang, 2018, Oncology letters.

Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH).

Yiqun Sun, T. Tong, Hui Zhang, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial

Hui Zhang, J. Wan, Yan Wang, 2023, Frontiers in oncology.

Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E)

Zhen Zhang, Hui Zhang, Yan Wang, 2023, BMJ Open.

Long-term outcomes in a retrospective cohort of patients with rectal cancer with complete response after total neoadjuvant therapy: a propensity-score weighted analysis

Xinxiang Li, Jing Zhang, Minghe Wang, 2023, Therapeutic advances in medical oncology.